Article: BIOSENSORS DES DEMONSTRATES EQUIVALENT SAFETY AND EFFICACY.

Article: Biosensors DES Demonstrates Equivalent Safety and ...
Heart Disease Weekly;  September 21, 2008 ;     700+ words ... ... next-generation drug-eluting stent, developed by Biosensors ... industry leading drug-eluting stent, CYPHER SELECT(TM ... of patients receiving the Biosensors DES, and 10.5 percent of ... first time that a drug-eluting stent with an abluminal biodegradable ...

Article: Biosensors DES Demonstrates Equivalent Safety and ...
PR Newswire;  September 1, 2008 ;     700+ words ... ... next-generation drug-eluting stent, developed by Biosensors ... industry leading drug-eluting stent, CYPHER SELECT(TM ... of patients receiving the Biosensors DES, and 10.5 percent of ... first time that a drug-eluting stent with an abluminal biodegradable ...

Article: Drug Eluting Stent Clinical Trial Analysis - An ...
M2 Presswire;  August 11, 2009 ;     700+ words ... ... 2009-Research and Markets: Drug Eluting Stent Clinical Trial Analysis - An Essential ... com/research/8f261a/drug_eluting_stent) has announced the addition of Global Markets Direct's new report "Drug Eluting Stent (DES) Clinical Trial Analysis" to ...

Article: Guidant Announces First Implant in SPIRIT FIRST Drug ...
Business Wire;  December 17, 2003 ;     700+ words ... ... feasibility trial evaluating an everolimus eluting stent system utilizing Guidant's MULTI ... studies demonstrated that an everolimus eluting stent with bioabsorbable polymer was safe ... of in-stent late loss. About Drug Eluting Stent Polymers Guidant's drug eluting ...

Article: Research and Markets: Drug Eluting Stent Clinical ...
Business Wire;  August 11, 2009 ;     700+ words ... ... com/research/c8d2ab/drug_eluting_stent) has announced the addition of Global Markets Direct's new report "Drug Eluting Stent (DES) Clinical Trial Analysis" to ... Global Markets Direct's " Drug Eluting Stent (DES) Clinical Trials Analysis ...

Article: First Patients Treated With Guidant's Drug-Eluting ...
Business Wire;  May 24, 2001 ;     700+ words ... ... the company's ACTION (ACTinomycin Eluting Stent Improves Outcomes by Reducing Neointimal ... supporting the PHARMA-LINK(TM) Drug Eluting Stent Program. The first clinical trial ... MULTI-LINK TETRA-D(TM) Drug Eluting Stent. This stent is designed to reduce ...

Article: Guidant Provides Overview of Drug Eluting Stent ...
Business Wire;  November 19, 2003 ;     700+ words ... ... of the company's progress in its drug eluting stent program at Guidant's annual Investor ... market for Guidant's first everolimus eluting stent, the CHAMPION(TM) Drug Eluting Stent System. Mead is announcing that ...